Submitted by Anonymous (not verified) on 12 August 2024 - 10:39
Human medicines European public assessment report (EPAR): Aybintio, bevacizumab, Date of authorisation: 19/08/2020, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Aybintio, bevacizumab, Date of authorisation: 19/08/2020, Revision: 8, Status: Authorised